STLN

Starling Oncology Inc.

STLN | NASDAQ
Chart Builder DCF Calculator
$6.53
-$0.12 (-1.80%)
At close: Oct 30, 2026, 3:59 PM ET
$6.41
-$0.12 (-1.84%)
Pre-market: Nov 2, 2026, 4:48 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
Net Income
-60.61M
Depreciation & Amortization
6.94M
Stock-Based Compensation
4.55M
Other Working Capital
1.11M
Other Non-Cash Items
23.23M
Deferred Income Tax
-32K
Change in Working Capital
1.33M
Operating Cash Flow
-24.59M
Capital Expenditures
-3.2M
Cash Acquisitions
n/a
Purchase of Investments
n/a
Sales Maturities Of Investments
n/a
Other Investing Acitivies
126K
Investing Cash Flow
-3.07M
Debt Repayment
-20.04M
Common Stock Repurchased
n/a
Dividend Paid
n/a
Other Financial Acitivies
-1.04M
Financial Cash Flow
11.56M
Net Cash Flow
-16.1M
Free Cash Flow
-27.79M
Adj. Free Cash Flow
-32.34M
Maintenance CapEx
-3.2M
Growth CapEx
n/a
Owner Earnings
-27.79M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.